1. Home
  2. Labeler Index
  3. Patriot Pharmaceuticals, Llc.
  4. 10147-0685
  5. NDC Package Code: 10147-0685-1 Methylphenidate Hydrochloride

NDC Package 10147-0685-1 Methylphenidate Hydrochloride

Tablet Oral - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
10147-0685-1
Package Description:
100 TABLET in 1 BOTTLE
Product Code:
10147-0685
Proprietary Name:
Methylphenidate Hydrochloride
Non-Proprietary Name:
Methylphenidate Hydrochloride
Substance Name:
Methylphenidate Hydrochloride
Usage Information:
Methylphenidate HCl Extended-Release Tablets are indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in children 6 years of age and older, adolescents, and adults up to the age of 65 [see Clinical Studies (14)].A diagnosis of Attention Deficit Hyperactivity Disorder (ADHD; DSM-IV) implies the presence of hyperactive-impulsive or inattentive symptoms that caused impairment and were present before age 7 years. The symptoms must cause clinically significant impairment, e.g., in social, academic, or occupational functioning, and be present in two or more settings, e.g., school (or work) and at home. The symptoms must not be better accounted for by another mental disorder. For the Inattentive Type, at least six of the following symptoms must have persisted for at least 6 months: lack of attention to details/careless mistakes; lack of sustained attention; poor listener; failure to follow through on tasks; poor organization; avoids tasks requiring sustained mental effort; loses things; easily distracted; forgetful. For the Hyperactive-Impulsive Type, at least six of the following symptoms must have persisted for at least 6 months: fidgeting/squirming; leaving seat; inappropriate running/climbing; difficulty with quiet activities; "on the go;" excessive talking; blurting answers; can't wait turn; intrusive. The Combined Type requires both inattentive and hyperactive-impulsive criteria to be met.
11-Digit NDC Billing Format:
10147068501
Billing Unit:
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
NDC to RxNorm Crosswalk:
100 EA
NDC to RxNorm Crosswalk:
  • RxCUI: 1091155 - methylphenidate HCl 18 MG 24HR Extended Release Oral Tablet
  • RxCUI: 1091155 - 24 HR methylphenidate hydrochloride 18 MG Extended Release Oral Tablet
  • RxCUI: 1091155 - methylphenidate hydrochloride 18 MG 24 HR Extended Release Oral Tablet
  • RxCUI: 1091170 - methylphenidate HCl 27 MG 24HR Extended Release Oral Tablet
  • RxCUI: 1091170 - 24 HR methylphenidate hydrochloride 27 MG Extended Release Oral Tablet
    • Product Type:
    Human Prescription Drug
    Labeler Name:
    Patriot Pharmaceuticals, Llc.
    Dosage Form:
    Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.
    Administration Route(s):
  • Oral - Administration to or by way of the mouth.
    • Active Ingredient(s):
  • METHYLPHENIDATE HYDROCHLORIDE 18 mg/1
    • Pharmacologic Class(es):
  • Central Nervous System Stimulant - [EPC] (Established Pharmacologic Class)
  • Central Nervous System Stimulation - [PE] (Physiologic Effect)
    • DEA Schedule:
    Schedule II (CII) Substances
    Sample Package:
    No
    FDA Application Number:
    NDA021121
    Marketing Category:
    NDA - A product marketed under an approved New Drug Application.
    Start Marketing Date:
    08-01-2000
    End Marketing Date:
    05-31-2025
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 10147-0685-1?

    The NDC Packaged Code 10147-0685-1 is assigned to a package of 100 tablet in 1 bottle of Methylphenidate Hydrochloride, a human prescription drug labeled by Patriot Pharmaceuticals, Llc.. The product's dosage form is tablet and is administered via oral form.

    Is NDC 10147-0685 included in the NDC Directory?

    Yes, Methylphenidate Hydrochloride with product code 10147-0685 is active and included in the NDC Directory. The product was first marketed by Patriot Pharmaceuticals, Llc. on August 01, 2000.

    What is the NDC billing unit for package 10147-0685-1?

    The contents of this package are billed per "each", products billed on a per each basis are usually products dispensed in discreet units. The calculated billable units for this package is 100.

    What is the 11-digit format for NDC 10147-0685-1?

    The 11-digit format is 10147068501. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-4-1 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-4-110147-0685-15-4-210147-0685-01